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Abstract
Nucleoporins build the nuclear pore complex (NPC), which, as sole gate for nuclear-cyto-
plasmic exchange, is of outmost importance for normal cell function. Defects in the process
of nucleocytoplasmic transport or in its machinery have been frequently described in human
diseases, such as cancer and neurodegenerative disorders, but only in a few cases of devel-
opmental disorders. Here we report biallelic mutations in the nucleoporin NUP88 as a novel
cause of lethal fetal akinesia deformation sequence (FADS) in two families. FADS comprises
a spectrum of clinically and genetically heterogeneous disorders with congenital malforma-
tions related to impaired fetal movement. We show that genetic disruption of nup88 in zebra-
fish results in pleiotropic developmental defects reminiscent of those seen in affected human
fetuses, including locomotor defects as well as defects at neuromuscular junctions. Pheno-
typic alterations become visible at distinct developmental stages, both in affected human
fetuses and in zebrafish, whereas early stages of development are apparently normal. The
zebrafish phenotypes caused by nup88 deficiency are rescued by expressing wild-type
Nup88 but not the disease-linked mutant forms of Nup88. Furthermore, using human and
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mouse cell lines as well as immunohistochemistry on fetal muscle tissue, we demonstrate
that NUP88 depletion affects rapsyn, a key regulator of the muscle nicotinic acetylcholine
receptor at the neuromuscular junction. Together, our studies provide the first characteriza-
tion of NUP88 in vertebrate development, expand our understanding of the molecular events
causing FADS, and suggest that variants in NUP88 should be investigated in cases of FADS.
Author summary
Fetal movement is a prerequisite for normal fetal development and growth. Fetal akinesia
deformation sequence (FADS) is the result of decreased fetal movement coinciding with
congenital malformations related to impaired fetal movement. FADS may be caused by
heterogenous defects at any point along the motor system pathway and genes encoding
components critical to the neuromuscular junction and acetylcholine receptor clustering
represent a major class of FADS disease genes. We report here biallelic, loss-of-function
mutations in the nucleoporin NUP88 that result in lethal FADS and with this the first
lethal human developmental disorder due to mutations in a nucleoporin gene. We show
that loss of Nup88 in zebrafish results in defects reminiscent of those seen in affected
human fetuses and loss of NUP88 affects distinct developmental stages, both during
human and zebrafish development. Consistent with the notion that a primary cause for
FADS is impaired formation of the neuromuscular junction, loss of Nup88 in zebrafish
coincides with abnormalities in acetylcholine receptor clustering, suggesting that defective
NUP88 function in FADS impairs neuromuscular junction formation.
Introduction
The nucleoporin NUP88 [MIM 602552] is a constituent of the nuclear pore complex (NPC),
the gate for all trafficking between the nucleus and the cytoplasm [1]. NUP88 resides on both
the cytoplasmic and the nuclear side of NPCs [2] and it is found in distinct sub-complexes: on
the cytoplasmic face it associates with NUP214 [MIM 114350] and NUP62 [MIM 605815] as
well as NUP98 [MIM 601021], while on the nuclear side NUP88 binds the intermediate fila-
ment protein lamin A [MIM 150330] [2–5]. The NUP88-NUP214 complex plays an important
role in the nuclear export of a subset of proteins and pre-ribosomes, which is mediated by the
nuclear export receptor CRM1 (Required for chromosome maintenance, alias exportin 1,
XPO1 [MIM 602559]) [6–8]. Depletion of NUP88 alters the intracellular localization of NF-κB
proteins [9–11]. Moreover, NUP88 is frequently overexpressed in a variety of human cancers
and its role therein appears linked to the deregulation of the anaphase promoting complex [12,
13] and its binding to vimentin [14].
Fetal movement is a prerequisite for normal fetal development and growth. Intrauterine
movement restrictions cause a broad spectrum of disorders characterized by one or more of
the following features: contractures of the major joints (arthrogryposis), pulmonary hypopla-
sia, facial abnormalities, hydrops fetalis, pterygia, polyhydramnios and in utero growth restric-
tion [15]. The unifying feature is a reduction or lack of fetal movement, giving rise to the term
fetal akinesia deformations sequence (FADS [OMIM 208150]) [16]. FADS is a clinically and
genetically heterogeneous condition of which the traditionally named Pena-Shokeir subtype is
characterized by multiple joint contractures, facial abnormalities, and lung hypoplasia result-
ing from the decreased in utero movement of the fetuses [15]. Affected fetuses are often lost as
NUP88 in fetal akinesia
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spontaneous abortions (in utero fetal demise) or stillborn. Many of those born alive are prema-
ture and die shortly after birth. In the past, the genetic basis for these disorders was frequently
unknown, but due to the recent availability of next generation sequencing, the molecular etiol-
ogy is becoming increasingly understood. Many cases of FADS result from impairment along
the neuromuscular axis and from mutations in genes encoding components of the motor neu-
rons, peripheral nervous system, neuromuscular junction and the skeletal muscle. Genes
encoding components critical to the neuromuscular junction and acetylcholine receptor
(AChR) clustering represent a major class of FADS disease genes, these include RAPSN [MIM
601592] [17, 18], DOK7 [MIM 610285] [19], and MUSK [MIM 601296] [20], as well as muta-
tions in the subunits of the muscular nicotinic acetylcholine receptor (AChR) [17, 21]. These
mutations are expected to affect neuromuscular junctions [22].
Here, we report a Mendelian, lethal developmental human disorder caused by mutations in
NUP88. We demonstrate that biallelic mutations in NUP88 are associated with fetal akinesia of
the Pena-Shokeir-like subtype. We confirm in zebrafish that loss of Nup88 impairs locomotion
behavior and that the mutant alleles are functionally null. We show that loss of NUP88 affects
protein levels and localization of rapsyn in cell lines and subject samples. Consistent with
altered rapsyn, AChR clustering in zebrafish is abnormal. We propose that defective NUP88
function in FADS impairs neuromuscular junction formation.
Results
Identification of NUP88 mutations in individuals affected by fetal akinesia
We performed exome sequencing and Sanger sequencing on genomic DNA from individuals
affected with FADS from two families (Fig 1A). Clinical and genetic findings are summarized
in Table 1, pedigrees and gene structure are shown in Fig 1A and 1B. Family A comprises four
affected individuals, three male and one female (Fig 1A; A.II.3, 4, 5, 7), and four healthy sib-
lings born to consanguineous parents of Palestinian origin. Exome sequencing of the last
affected fetus A.II.7 revealed a homozygous missense mutation c.1300G>T (p.D434Y) in the
NUP88 gene [NM_002532.5] (Fig 1A), absent in relevant databases (dbSNP, Ensembl, UCSC,
TGP, ExAC, HGMD, gnomAD). Sanger sequencing revealed identical homozygous missense
mutation in the third affected fetus (Fig 1A, A.II.5; S1A Fig). Both parents and unaffected sib-
lings A.II.1, A.II.2 and A.II. 6 are heterozygous carriers of the mutation, unaffected sibling A.
II.8 carries two intact alleles of NUP88 after in vitro fertilization and preimplantation diagnos-
tic (Fig 1A). DNA was unavailable from the first and second miscarriage (A.II.3 and A.II.4),
but clinical phenotypes resemble those of the two affected individuals A.II.5 and A.II.7
(Table 1). In Family B, one affected son was born to healthy unrelated parents of European
descent. Exome sequencing in the affected individual, his parents and his two unaffected sibs
(S1B Fig) revealed that the individual is compound heterozygous for two NUP88 mutations,
i.e. a nonsense c.1525C>T (p.R509�) and a single amino-acid deletion c.1899_1901del (p.
E634del; Fig 1A; B.II.2), absent in relevant databases. Parents and healthy siblings were hetero-
zygous carriers of the one or the other of the mutations, thus confirming correct segregation
consistent with recessive inheritance (Fig 1A). The missense substitution p.D434Y and dele-
tion p.E634del affect evolutionary highly conserved NUP88 residues (Fig 1B) indicating func-
tional relevance. Accordingly, SIFT/Provean, Polyphen-2, and MutationTaster predicted both
mutations to be disease causing or potentially pathogenic (S1 Table).
Analysis of protein structure
To gain further insights into the impact of the NUP88 mutations on NUP88 protein function,
we performed structural modelling as the crystal structure of human NUP88 is not known.
NUP88 in fetal akinesia
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Models obtained (see Methods) predicted the N-terminal domain (NTD) to form a 7-bladed
ß-propeller, set up in a (4, 4, 4, 4, 4, 4, 3) arrangement of ß-strands and no Velcro lock as typi-
cal for classical ß-propellers (Fig 2A). Around 60 residues precede the ß-propeller and are
located at the bottom or side of the propeller thereby shielding 2–4 blades in their vicinity (Fig
2A). The model reveals high similarity to the PDB deposited structures of Nup82 from Baker’s
yeast and Nup57 from Chaetomium thermophilum (Fig 2B). The most prominent differences
are a loop region and a helix-turn-helix (HTH) motif emanating from blades 4 and 5, respec-
tively (Fig 2B). Models obtained for NUP88’s C-terminal domain (CTD) exhibited low reliabil-
ity, but the CTD, in analogy to its yeast homolog, is likely composed of extended α-helices (Fig
2C) that form trimeric coiled-coils, either in cis or in trans. In this context, an arrangement
Fig 1. NUP88 mutations identified in affected individuals from two families. (A) Pedigrees of two families identified with mutations in
NUP88 (GenBank: NM_002532.5). (B) NUP88 gene and protein structure, location of the identified mutations, and phylogenetic
conservation of the mutated residues and surrounding amino acids. Identical amino acids are indicated by asterisks, highly similar residues
by colons.
https://doi.org/10.1371/journal.pgen.1007845.g001
NUP88 in fetal akinesia
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with its complex partners NUP214 and NUP62 in trans is most likely, as described for the
yeast counterpart of the complex [23, 24].
According to the model structure, the p.D434Y mutation is located in the loop of a HTH
motif between the two outermost ß-strands of blade 6 (Fig 2B, overall view; Fig 2D,
Table 1. Genetic and clinical data of affected individuals with NUP88 variants.
Family HPO A B
ID A.II.3 A.II.4 A.II.5 A.II.7 B.II.2
Gender M M M F M
Genotype NUP88 No DNA available No DNA
available
Homozygous
c.1300G>T
Homozygous
c.1300G>T
Compound
heterozygous
c.1525C>T/
c.1899_1901del
Duration of pregnancy
(age at death/ stillborn/
terminated pregnancy)
36 1/2 gw
(death at 2 d)
20 gw
(intrauterinedeath)
32 gw
(intrauterine demise)
21.5 gw
(tp)
28 5/7 gw
(tp)
Neuromuscular system
Decreased fetal
movements (gw at
diagnosis)
HP:0001558 X (23+4 gw) X (20 gw) X (23 gw) X (20 gw) X
Polyhydramnios HP:0001561 X X
Arthrogryposis
multiplex congenita
HP:0002804 X X X X X
Fingers, hands, elbow,
dislocated hip, fractured
tibia, rocker bottom feet
Face, hyperextended fetal neck,
mandibular contracture, elbow,
wrist, fingers, camptodactyly,
calves, feet
Fingers, hands,
elbow, feet, knees
Fingers, wrist,
elbow, feet, knees
Underdeveloped muscle
(Reduced muscle bulk/
hypoplasia/ atrophy)
HP:0009004 Muscle atrophy ND Muscle atrophy upper arms,
bulbous on forearms, swelling
of calf muscles
ND Upper arms thin,
lower arms
bulbous
Dysmorphic signs
Low-set, posteriorly
rotated ears
HP:0000368 X ND X ND X
High broad nasal bridge HP:0000426 X ND X X X
High-arched palate HP:0000218 X ND X ND X
Microretrognathism HP:0000308 X ND X ND X
Reduced number of rib
pairs (11 instead of 12)
HP:0000878 11 ND 12 ND 11
Undescended testis HP:0000028 R+L NA L NA ND
Neck Short ND Hyperextended ND Broad
Other Polyhydramnios No heart tones at
20 gw
29+4 gw body edema Polyhydramnios
Absent stomach bubble Bilateral pleural effusions Reduced stomach
filling
Ascites
Severe respiratory distress
Small lungs in X-ray
Apnea
Severe kyphosis
Fetal bradycardia
gw: gestational week; tp: terminated pregnancy
https://doi.org/10.1371/journal.pgen.1007845.t001
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magnification). The mutation likely leads to a decrease in the interaction with one of the
neighboring proteins, thereby leading to a destabilization of the complex. The nonsense muta-
tion c.1525C>T resulting in p.R509� is located just after the ß-propeller in the linker region to
the CTD resulting in a complete loss of all α-helices. Thus, the interaction of NUP88 with its
complex partners is likely reduced to only propeller interactions, if the protein is not
completely lost due to nonsense mediated decay of the mRNA. The p.E634del mutation is
located in the middle of the CTD sequence and predicted to lie in the last fifth of an extended
helix. The deletion results in a frame-shift of the remainder of the α-helix, which shifts the fol-
lowing residues by about a third of a helical turn and thus disrupts the interaction pattern of
all following residues, which, as a consequence, decreases the overall stability of the interac-
tions within this helix bundle.
Fig 2. Modelling of human NUP88. (A) The N-terminal domain of NUP88 reveals a seven-bladed ß-propeller with
an N-terminal extension. The rainbow coloring indicates N-terminal residues in blue (NTD = N-terminal domain)
and C-terminal residues of the propeller in red. Individual blades are indicated by numbers. The red arrow indicates
the location of the p.D434Y point mutation (see below for details). (B) Overlay of the NUP88 model (red) with the X-
ray structures of Nup82 from baker’s yeast (PDBid: 3pbp, in gray) and C. thermophilum (PDBid: 5cww; in light
yellow). Significant differences between species are in blade 4 (HTH-motif; black arrow) and 5 (extended loop; blue
arrow). (C) Composite model of the N- and C-terminal regions of NUP88. The presented model was generated using
RaptorX with its standard settings and misses about 40 amino acid residues after the propeller region. Both, the
propeller and CTD regions are colored in rainbow coloring as in (A). The individual mutations are indicated by their
numbering and represented in sphere mode. (D) Magnification of the loop bearing the D434 mutation in NUP88 in
stick mode. The coloring of the individual molecules is as described in (B).
https://doi.org/10.1371/journal.pgen.1007845.g002
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Danio rerio nup88 model
FADS is a developmental disorder and to study the function of NUP88 in vertebrate develop-
ment, we used a zebrafish (D. rerio) model. We first examined the spatial expression of nup88
during embryonic development. The single zebrafish nup88 orthologue
(ENSDARG00000003235) encodes a protein of 720 amino acid translated from a single 2410
bp transcript. The predicted translated gene product shares 63% identity and 75% similarity
with human NUP88. Whole-mount in situ hybridization (WISH) and RT-PCR analysis in
wild-type AB zebrafish showed that nup88 transcripts are maternally deposited early in devel-
opment (S2A and S2B Fig, four-cell-stage embryos) and then ubiquitously expressed at 5
hours post fertilization (hpf). By 24 hpf, while expressed ubiquitously, particularly high levels
of nup88 mRNA were detected in highly proliferative frontal regions of the embryo, i.e. the
central nervous system, brain, eye and anterior trunk. At 72 hpf, nup88 transcript levels are
decreasing in these frontal regions and only slightly higher than in other regions of the zebra-
fish larvae. Similar expression patterns in the developing zebrafish have been described for the
two NUP88-binding partners, NUP98 and NUP62 [25, 26].
Genetic disruption of nup88 affects zebrafish development
To study the impact of nup88 deletion on zebrafish development, we used the nup88sa2206 allele
generated by the Zebrafish Mutation Project [27, 28]. Heterozygous nup88sa2206 carriers were
outcrossed for four generations with wild-type AB zebrafish prior to phenotypic analysis. The
nup88sa2206 allele is characterized by a nonsense mutation, c.732T>A (Fig 3A), resulting in a
premature stop codon at amino acid 244. nup88 mRNA levels are reduced by about 90% in 5
dpf nup88 mutants (see below), suggesting that the mRNA is subjected to nonsense-mediated
decay. For the purpose of this study, nup88sa2206/sa2206 is therefore referred to as nup88-/-. Dur-
ing early stages of development and up to 3 dpf, no marked differences in morphological fea-
tures of nup88-/- compared to nup88+/+ and nup88+/- siblings were observed. Starting at 4 dpf,
phenotypic alterations became visible: smaller head and eyes, lack of a protruding mouth,
downwards curvature of the anterior-posterior axis, abnormal gut and aplastic swim-bladder
(Fig 3B). Further analyses of the cranial abnormalities revealed that nup88-/- larvae exhibit
severe defects in the ventral viscerocranium formed by seven cartilaginous pharyngeal arches
[29, 30]. In nup88-/- larvae, the posterior pharyngeal arches 3–7 were dramatically reduced, dis-
torted or even absent (Fig 3C). The reduced size of head and eyes correlated with an increase in
apoptosis in the head of nup88-/- embryos (Fig 3D). Apoptotic cells, as assessed by acridine
orange staining, were readily detected in the eyes, the brain and the anterior trunk of 35 hpf
mutant embryos, but not in other parts of the body (S2C Fig). Together, these data indicate that
nup88 mutants are phenotypically similar to the large class of jaw and branchial arch zebrafish
mutants, designated as the flathead group [31, 32]. Disruption of nup88 furthermore led to
impaired survival with lethality occurring at or after 9 dpf (Fig 3E).
FADS-related mutations in nup88 lead to a loss-of-function phenotype
To address the question whether NUP88 mutations identified in the familial cases of FADS
affect NUP88 function, we performed phenotypic rescue experiments in zebrafish. Two of the
three mutated residues in the uncovered FADS cases are conserved between human and zebra-
fish (Fig 1B), hence we introduced the corresponding mutations on zebrafish expression con-
structs by site-directed mutagenesis. Human c.1300G>T, p.D434Y corresponds to c.1240G>T,
p.D414Y in zebrafish and human c.1899_1901del, p.E634del to zebrafish c.1837_1839del, p.
E613del. Human p.R509 is not conserved in zebrafish, therefore we inserted a stop codon at
c.1468-1470>TGA, p.H490�, a residue in a similar position as human R509. Subsequently
NUP88 in fetal akinesia
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synthetic mRNA corresponding to each variant was microinjected into one-cell stage nup88-/-
mutants and their rescue capacity was assessed by evaluating the eye size as well as the number
and morphology of the pharyngeal arches. Injection of wild-type (WT) nup88 mRNA partially
rescued the developmental defects of the 5 dpf mutant larvae as indicated by significant
Fig 3. Morphological phenotypes of nup88-/- mutants. (A) nup88 gene structure and location of the mutation in the
sa2206 allele. (B) Lateral view of wild-type and nup88-/- embryos at 5 dpf. nup88-/- mutants resemble the flathead group of
mutants characterized by decreased head and eye size and the absence of a protruding mouth (black arrowhead). The
larvae furthermore show aplastic swim bladder (white arrowhead), hypoplastic liver, abnormal gut and a marked curvature
of the anterio-posterior axis. (C) Higher magnification lateral views of the head region of wild-type and nup88-/- embryos
at 5 dpf. Alcian blue staining of the viscerocranium revealed that nup88-/- mutants lack pharyngeal arches 3 to 7 (P3-7). A
ventral view of the head showed that hyoid and mandibular arches (P1 and P2) were present, but dysmorphic. A schematic
representation of the viscerocranium is shown to illustrate alcian-blue images. Genotypes of larvae were determined by fin
clip and RFLP. m, Meckel’s cartilage; ch, ceratohyal; pq, palatoquadrate; cb, ceratobranchials (P3-7); hs, hyosymplectic. (D)
Acridine orange staining revealed an increase in apoptotic cells in the head, including the eyes (arrowhead), the brain
(filled arrow), and anterior part of the trunk (arrow) of nup88-/- mutants at 35 hpf compared with wild-type siblings.
Shown are confocal images. Scale bars, 100 μm. (E) Survival curves of nup88 mutants and siblings. 75 larvae were analyzed
in each category. Error bars are ±SEM.
https://doi.org/10.1371/journal.pgen.1007845.g003
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restoration of the eye size (Fig 4A and 4B) and a significant increase in the number of pharyn-
geal arches (Fig 4A and 4C). In addition, the arches resembled the morphologically wild-type
Fig 4. Wild-type nup88, but not disease-related mutant forms, rescue defects of nup88-/- embryos. (A) nup88+/- embryos were in-crossed and 300 pg of
mRNA encoding wild-type or the respective mutant nup88 were microinjected at the one-cell stage. The extent of rescue of each variant mRNA was evaluated
after 5 dpf using (B) the diameter of the eye (One-way ANOVA test), (C) the number of pharyngeal arches (Kruskal-Wallis test) and (D) their morphology as
readouts. Only injecting wild-type, but not the mutant forms of nup88 mRNA, rescued the reduced eye size and the number of pharyngeal arches as revealed by
Alcian blue staining (A). At least three independent injections were performed for each condition. Values are mean ± SD. Significance in comparison to nup88+/+
and nup88-/- embryos, respectively. n.s., non- significant, �P<0.05, ��P<0.01, ���P<0.001, ����P<0.0001. The statistical annotations appearing just above the
histogram bars refer to the comparison to the uninjected mutants. n is number of embryos/larvae analyzed. In (D) 21 larvae from 3 independent experiments
(3x7) were analyzed for each form.
https://doi.org/10.1371/journal.pgen.1007845.g004
NUP88 in fetal akinesia
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structures (Fig 4A and 4D). In contrast to WT nup88 mRNA, injection of nup88 D414Y
mRNA, nup88 H490� mRNA as well as nup88 E613del mRNA failed to suppress the nup88-/-
phenotypes (Fig 4A–4D), indicating that these nup88 mutant transcripts are functionally null.
Although the results suggest that the encoded variant proteins are functionally inactive, the lack
of rescue could also be the consequence of transcript or protein instability.
nup88 mutants show strongly impaired locomotor behavior
To further investigate the implication of NUP88 in the etiology of FADS, we next determined
whether locomotor function was impaired by loss of Nup88 using locomotion and touch-
evoked escape assays in nup88-/- zebrafish. Zebrafish embryos develop spontaneous muscle
contractions at 18 hpf [33], therefore we first analyzed the coiling behavior of nup88-/- embryos
as compared to nup88+/+ and nup88+/- embryos at 22–24 hpf. We did not detect problems in
coiling behavior in nup88-/- embryos at this developmental stage (S3A Fig and S1 Movie).
Next, we analyzed spontaneous swimming activity at 4 dpf (Fig 5A) and found that only about
35% of the nup88-/- larvae showed spontaneous movement as compared to ~83% of nup88+/+
and about 73% of nup88+/- larvae (Fig 5B). Moreover, those moving nup88-/- larvae displayed
drastically reduced motor activity, traveled shorter distance (Fig 5C) and initiated swim bouts
less often (Fig 5D). In contrast, statistically significant differences in the mean velocity were
not observed in nup88 mutant larvae (Fig 5E).
We next performed touch-evoked escape response assays at 3 dpf and 4 dpf. At 3 dpf, per-
centages of responsive animals and response duration were not significantly different between
wild-type and nup88 mutant larvae (S3B Fig). At 4 dpf, percentages of responsive animals were
also not significantly different between wild-type and nup88 mutant larvae (Fig 5F), however,
the response duration among the larvae that moved was significantly reduced in homozygous
nup88 mutants in comparison to wild-type zebrafish. Interestingly also heterozygous nup88
mutants showed a shortened response duration, although less significant (Fig 5G and 5H and
S2–S4 Movies).
FADS-related mutations in NUP88 alter NUP88 interactions
Next we wanted to assess whether the NUP88 mutations identified in the individuals with
FADS interfere with the recruitment of NUP88 to NPCs. Due to a lack of relevant cell lines
and the limited availability of tissue samples from affected fetuses, we performed immunofluo-
rescence microscopy of GFP-tagged NUP88 proteins. Upon expression in HeLa cells, wild-
type NUP88 and all mutants were co-localizing with the NPC marker mAb414, although
recruitment of the NUP88 p.R509� and p.E634del mutants to NPCs appeared reduced com-
pared to wild-type NUP88 and the p.D434Y mutant (S4A Fig). Moreover, all forms of NUP88
also localized partially to the cytoplasm, as previously seen for NUP88 overexpression [2, 12],
and NUP88 p.R509� to the nucleoplasm (S4A Fig). To define the effect of the mutations in
NUP88 on the interface with its binding partners NUP214, NUP98 and NUP62, we employed
GFP trap affinity purification in combination with Western blot analysis of lysates from HeLa
cells expressing the GFP-NUP88 mutants. We found that NUP88 and the p.D434Y mutant co-
purified NUP214 and NUP62, while the p.R509� and the p.E634del mutant did not so (Fig
6A). Binding of NUP214 to GFP alone was similar as compared to the p.R509� and the p.
E634del mutants, indicating some non-specific binding of the NUP214 and/or the antibodies
to GFP. The disrupted interaction between NUP88 and NUP214, however, did not impair
NUP214 localization at NPCs (Fig 6B), whereas NUP62 association with NPCs was reduced in
cells expressing NUP88 E634del (Fig 6C). Our GFP trap assays further showed that NUP98
associated with NUP88 and all mutant forms (Fig 6A). Consequently, NUP98 association with
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NPCs appeared unaffected in cells expressing NUP88 mutants (Fig 6D). Furthermore, the dis-
ease-related mutations in NUP88 did not affect the organization of the nuclear envelope as
revealed by immunofluorescence analysis of lamin A/C (LA/C;S4B Fig), Western blots analysis
of protein levels of lamin A/C and GST-pull-down down assays with NUP88 and the p.D434Y
mutant (S4C and S4D Fig and S1 Methods). Moreover and consistent with data from higher
vertebrates, NUP88 appears to not be essential for NPC integrity: immunolabelling of NPCs
using a monoclonal antibody (mAb414) recognizing a subset of nucleoporins appears unaf-
fected by the loss of nup88 in D. rerio brain sections (S4E Fig and S1 Methods) and in muscle
histology sections of individual B.II.2 (S4F Fig). Additionally, depletion of NUP88 from HeLa
cells using siRNAs had no visible effect on the distribution of lamin A/C (LA/C) and the NE
marker proteins emerin, Nesprin-1, Nesprin-2, Sun1, and Sun2 (S5 Fig).
Fig 5. nup88 mutants display motor impairments. (A) Images showing representative examples of motion tracking (red lines) of 4 dpf nup88 homozygous and
heterozygous mutants, and wild-type controls during one-minute long spontaneous locomotion recordings. (B) Quantification of percentages of larvae displaying
spontaneous movement, also shown as (number of moving larvae/total number of larvae). Beeswarm graphs with individual data points depicting distance travelled/
minute (C), bouts/minute (D), and mean velocity of swimming bouts (E) of nup88 mutants and wild-type controls displaying spontaneous locomotion. (F) Quantification
of percentages of larvae displaying touch-induced escape response, also shown as (number of responsive larvae/total number of larvae). (G) Representative examples of
touch-induced escape behavior of 4 dpf head-restrained nup88 mutant and wild-type larvae. The first column depicts single frames taken 50 ms before an escape response
was induced by touching the trunk of larvae with a pipette tip (red dashed lines). The other columns show superimposed frames of escape responses at consecutive time
intervals after touch. The asymmetric tail movement displayed in some of the images (nup88+/- and nup88-/- at 201–400 ms, and all genotypes at 401–600 ms) represents
slow motion of the tail toward its original position. The escape response terminated before this phase (see also S2–S4 Movies). (H) Graph showing average durations of
escape response in nup88 mutants and wild-types. � p< 0.05, �� p< 0.004, ��� p = 0.001, n.s. = non-significant, two-tailed Fisher exact test (B and G) or two-tailed t-test
(C-E, H). Data in C-E and H are shown as mean ± SD. n is number of embryos/larvae analyzed.
https://doi.org/10.1371/journal.pgen.1007845.g005
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Fig 6. NUP88 mutants have distinct effects on NUP88 nucleoporin partners. (A) GFP-trap assays to study the effects of NUP88 mutants on its
interaction with NUP214, NUP62 and NUP98. GFP and GFP-NUP88 fusion proteins were transiently expressed in HeLa cells. After 48 h, GFP
proteins and associated factors were recovered from cell lysates and probed by Western blot analysis using antibodies against Nup214, NUP62, and
NUP98. Successful transfection and expression of the proteins was confirmed by probing with antibodies against GFP. GFP proteins had the
following size: GFP-NUP88 WT, D434Y, and E634del: ~115 (88 + 27) kDa; GFP-NUP88 R509�: 83 (56 + 27) kDa; GFP: 27 kDa. (B-D) HeLa cells
were transiently transfected with GFP-constructs of the respective NUP88 mutant and fixed and stained after 48 h for immunofluorescence
microscopy using (B) anti-NUP214, (C) anti-NUP62, and (D) anti-NUP98 antibodies. Only NUP88 E634del affects NUP62 association with
NPCs. Scale bars: 10 μm.
https://doi.org/10.1371/journal.pgen.1007845.g006
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As NUP88 is critically involved in CRM1-dependent nuclear export of proteins, we further
asked whether the mutations in NUP88 affect nuclear import and/or export, but we observed
no defects in general nuclear protein import or export (S6A Fig) or the three CRM1 targets
mTOR, p62/SQSTM and TFEB (S6B Fig).
Loss of NUP88 affects rapsyn levels and localization
Impeded formation of AChR clusters at the neuromuscular junction (NMJ) is one cause of
FADS. Given the central role of rapsyn in AChR clustering and in FADS [17, 18, 21], we there-
fore asked whether a loss of NUP88 function would negatively affect rapsyn and depleted
NUP88 by siRNAs from HeLa and C2C12 cells and monitored protein levels of rapsyn by
Western blotting. As shown in Fig 7A, depletion of NUP88 from HeLa cells in fact coincided
with a decrease in rapsyn levels. Similarly, reduced rapsyn levels were observed in C2C12 cells
depleted for NUP88 using siRNAs (Fig 7B and 7C) and shRNAs (Fig 7C). Quantification
revealed that siRNA treatment led to reduction of NUP88 by 80–90% and at the same time a
reduction of rapsyn by 40–60% (Fig 7C). In contrast to that, NUP88 downregulation had no
effect on MuSK levels, another key player in FADS [20], and no effect on known NUP88 tar-
gets, such as CRM1 and NF-κB levels (Fig 7A and 7B). Muscle biopsy of affected individual B.
II.2 and immunohistochemistry on paraffin sections furthermore showed weaker staining and
irregular distribution of rapsyn in the cytoplasm in comparison to biopsy samples from a con-
trol fetus (Fig 7D). Rapsyn is known to not only localize to the plasma membrane, but also to
the cytoplasm [34–36]. Rapsyn protein levels could not be determined in zebrafish due to a
lack of antibodies, but qRT-PCR analyses revealed a reduction of rapsn mRNA by about 20%,
while nup88 mRNA levels were reduced by about 90% (Fig 7E).
Consistent with reduced rapsyn levels, we observed impaired AChR clustering in fast-
twitch muscle fiber synapses, but not in myoseptal synapses of the 5 dpf zebrafish trunk (Fig
7G). Quantification of the size of individual AChR cluster in WT and mutant zebrafish
revealed that the diameter of the AChR clusters was significantly reduced in nup88-/- larvae as
compared to nup88+/+ larvae (Fig 7H). Interestingly, AChR cluster size was also reduced in
nup88+/- larvae, both in comparison to WT and nup88-/- larvae. This reduced size of AChR
clusters in the heterozygotes may account for the observed defects in touch-evoke response
(Fig 5H). In accordance with impaired neuromuscular junction formation as a consequence of
loss of nup88, muscle organization in zebrafish appeared indistinguishable in electron micro-
graphs from nup88+/+ and nup88-/- larvae (Fig 7F). Similarly, in affected fetus B.II.2 skeletal
muscle structure was, based on the autopsy report, intact. Thus, both in vitro and in vivo evi-
dence support the notion that loss-of-function of NUP88 has a negative effect on rapsyn,
which likely affects AChR clustering and proper formation of neuromuscular junctions.
Discussion
Here, we have identified biallelic homozygous and compound heterozygous mutations in
NUP88 as a cause of fetal akinesia. We demonstrate that the mutations in NUP88 lead to a
loss-of-function phenotype, which coincides with reduced spontaneous motor activity and
touch-evoked escape response in zebrafish. Consistent with the fact that the mutations in
NUP88 affect different regions of the protein, we observed distinct effects of the mutants on
binding to NUP214 and NUP62 in GFP-trap assays, whereas binding to NUP98 appears indis-
tinguishable between wild-type and mutant forms of NUP88 (Fig 6A). This suggests that
impaired interaction with partner nucleoporins may contribute, but are unlikely to be causa-
tive for NUP88 malfunction in FADS. Our data further suggest that NUP88 malfunction in
FADS is at least in part due to dysfunctional rapsyn, a known key player in FADS, and
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Fig 7. Loss of functional NUP88 affects rapsyn expression as well as AChR clustering. (A) HeLa and (B) C2C12 cells were treated with the indicated
siRNAs for 2 days and cellular lysates were subjected to Western blot analysis using antibodies against NUP88, CRM1, MuSK, NF-kB, and rapsyn.
GAPDH was used as loading control. Rapsyn protein levels are reduced in NUP88-depleted cells. Note MuSK has a predicted molecular weight of 97
kDa, but migrates higher [20]. (C) Quantification of the respective expression levels of NUP88 and rapsyn after transfection of HeLa and C2C12 cells
with the indicated siRNAs and shRNA-mediated depletion of NUP88 in C2C12 cells. Blots from three independent experiments for each condition were
analyzed. Data present mean ± SEM. P-values ����<0.0001, ���<0.001; ��<0.01, �<0.05; t-test, one-tailed. (D) Bright-field images of histological muscle
sections from individual B.II.2 and a control fetus stained with anti-rapsyn antibodies (brown). Nuclei were visualized by hematoxylin. (E) qRT-PCR
analysis of nup88 and rapsn transcripts in 5 dpf wild-type and nup88-/- larvae. (F) Skeletal muscle organization remains unaffected in nup88-/- zebrafish
larvae. Larvae were prepared at 5 dpf for transmission electron microscopy. Skeletal muscle of WT and mutant zebrafish show intact myofibril
alignment with their regularly stacked Z-line and clearly identifiable H- and I-zones. Shown are representative longitudinal sections of skeletal muscle
from nup88+/+ and nup88-/- larvae, respectively. Scale bar, 1 μm. (G) Anterior trunk regions of wild-type (left) and nup88 heterozygous and homozygous
mutant larvae were stained with antibodies against the AChR and secondary Alexa 488 antibodies. AChR cluster size was significantly reduced in
nup88-/- larvae as compared to nup88+/+ and nup88+/- larvae (higher magnification insets). Insets are taken from the marked area in the respective
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consequently impaired AChR clustering and neuromuscular junction formation. Muscle
integrity, in contrast, appears grossly unaffected by a loss of NUP88.
Genetic disruption of nup88 in zebrafish led to pleiotropic morphological defects, including
micrognathia, smaller head and eyes, distortion of the body axis, and aplastic swim bladder
(Figs 3 and 4), and to impaired locomotor behavior (Fig 5). These phenotypes parallel defects
observed in human fetuses affected by FADS, such as reduced fetal movement, micrognathia,
joint contractures and lung hypoplasia (for detailed comparison see Table 2). The reduced
head and eye size likely originates from increased apoptosis of neuronal cells (Fig 3D). nup88
inactivation affected spontaneous movement of zebrafish from 4 dpf onwards, which resem-
bles the onset of symptoms in the affected fetuses at about week 18 of gestation. The impaired
touch-evoked response seen in the mutant zebrafish further matches the absence of reflex
response observed in at least some fetuses (Family A, I.2 and B.F., personal communication).
Rescue experiments in zebrafish with wild-type or nup88 mutants revealed that none of the
mutant mRNA could restore a wild-type-like phenotype (Fig 4), indicating that NUP88 muta-
tions in individuals affected with FADS are loss-of-function variants. The zebrafish model
developed here therefore provides a valuable in vivo system to further test nup88 deficiency.
This in turn will be key in understanding the role of NUP88 in the etiology of FADS and its
function in embryonic development.
Reduced rapsyn levels might partly cause fetal akinesia upon loss of NUP88. Rapsyn is one
of the many contributing proteins required for the correct assembly of the AChR and is partic-
ularly involved in AChR assembly and localization to the cell membrane [37, 38]. We observed
reduced rapsyn protein levels in the absence of functional NUP88 in cellular assays using
human and mouse cell lines in combination with siRNA and shRNA-mediated depletion of
NUP88 (Fig 7). Due to a lack of cell lines derived from affected individuals, we could analyze
rapsyn only in histological sections from muscle of one affected fetus, which revealed a weaker
staining for and a perturbed intracellular localization of rapsyn (Fig 7D). Consistent with aber-
rant rapsyn expression, AChR clustering in trunk regions of nup88+/- and nup88-/- zebrafish
was impaired (Fig 7G and 7H). Rapsyn protein levels could not be determined in zebrafish due
to a lack of antibodies, but qRT-PCR analyses revealed a reduction of its mRNA by about 20%
(Fig 7E). Our data therefore suggest that absence of functional NUP88 causes fetal akinesia at
least in part through misregulation of rapsyn expression. How loss of NUP88 results in
reduced rapsyn levels on a mechanistic level remains to be seen. Moreover, this likely is not
overview image. Inset for nup88-/- was rotated by 180˚. Scale bars, 50 μm (overview), 5 μm (insets). (H) Quantification of the AChR size in 4 dpf nup88+/
+ (n = 8), nup88+/- (n = 14), and nup88-/- (n = 12) larvae. Per larvae 100 clusters throughout z-stacks of confocal images were manually measured using
ImageJ. Data present mean ± SD. P-values ����<0.0001, ���<0.001; t-test, one-tailed.
https://doi.org/10.1371/journal.pgen.1007845.g007
Table 2. Phenotypic similarities between nup88-/- zebrafish and FADS fetuses.
Danio rerio FADS fetuses Comments
Impaired locomotor behaviour Progressive akinesia
Decreased head and eye size Microcephaly Not in all FADS cases
examined
Flat head without protruding mouth Flat face
Lack of pharyngeal arches, dysmorphic
jaw
Micrognathia
Curvature of the anterior-posterior axis Multiple joint contractures, deformed
limbs
Aplastic swim bladder Pulmonary hypoplasia
https://doi.org/10.1371/journal.pgen.1007845.t002
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the only pathway by which NUP88 acts in NMJs, as effects on only one cellular pathway would
be indeed (i) very surprising for a nucleoporin per se, (ii) irreconcilable with the cranial defects
observed in human and zebrafish, and (iii) not in line with the broad central nervous system
expression pattern of nup88 in zebrafish. Our data, however, demonstrate (i) that the nup88
spectrum of phenotypes indeed include locomotor defects and that therefore NUP88 deficien-
cies might result in FADS in humans, and (ii) that human alleles are dysfunctional. We further
observed that (iii) NMJ defects correlate to this phenotype. Whether this is the primary cause
of akinesia is impossible to determine given the pleiotropic effects of Nup88 deficiency, but at
least they are sufficient to explain the phenomenon. Further mechanistic details will be subject
for future studies.
Materials and methods
DNA sequencing family A
Exome sequencing in one affected baby (A.II.7) was performed at the Clinical Exome Sequenc-
ing (CES) at University of California, Los Angeles and the sequencing report is on hand. In
total 22,843 DNA variants were identified, including 21,625 single nucleotide substitutions
and 1,218 small deletions/insertions (1–10 bp): the data were consistent with a high quality
genomic sequence and fall within normal human genomic variation quality parameters. Esti-
mated from these data, about 93% of the exome was reliably sequenced with at least 10x cover-
age. In total, 5 homozygous and 329 rare heterozygous protein-altering variants of uncertain
clinical significance were identified across 313 genes. A rare autosomal-recessive model of
inheritance with homozygous causative mutations due to consanguinity of the parents was
assumed. After applying appropriate filters, a novel homozygous variant c.1300G>T, p.D434Y
in the NUP88 gene [NM_002532.5] was identified in the subject’s DNA. This variant had not
been previously observed in the general population and was predicted to be deleterious/proba-
bly damaging by three in silico prediction algorithms (S1 Table). Additionally, the homozygous
mutation c.1300G>T, p. D434Y in NUP88 was confirmed in a second affected fetus A.II.5 by
Sanger sequencing.
DNA sequencing family B
Exome sequencing was performed on DNA from the proband B.II.2, both healthy sisters and
both parents from the European family, as outlined previously [39]. Exome enrichment was
performed on DNA using an Ampliseq Whole Exome kit, (Thermo Fisher Scientific). Briefly,
a total of 100 ng of DNA was amplified in 12 separate PCR pools, each containing ~25,000
primer pairs. After amplification, the individual reactions were pooled and digested to degrade
the PCR primers. Next, barcoded sequencing adaptors were ligated and the library was puri-
fied using AMPure beads (Beckman Coulter), amplified and purified again and analyzed on a
2100 Bioanalyzer (Agilent Technologies). Libraries were diluted to 18–26 pM and attached to
Ion Sphere Particles (ISPs) using an Ion Proton Template 200 V3 kit and sequenced on a P1
sequencing chip for 520 flows on an Ion Proton sequencer (Ion Sequencing 200 kit V3). Two
samples were pooled and sequenced on a single chip. Following sequencing, reads were
trimmed to remove low quality bases from the 3’ end and mapped to the human genome refer-
ence sequence (HG19) using tmap (Torrent Suite 4.2). Variant calling was performed using
the Torrent Variant Caller with custom settings optimized for whole exomes and the data was
annotated using ion Reporter 4.0. Variants were filtered with ANNOVAR [40] against
ENCODE GENECODE v.19, 1000genomes (threshold >0.5%), dbSNP138 common databases
and against a list of in-house common variants. Genes with variants that fitted an autosomal
recessive inheritance pattern and co-segregated with disease in the family were prioritized.
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NUP88 was the only candidate gene that harbored variants compatible with an autosomal
recessive inheritance pattern in this family (S1B Fig). Individual B.II.2 was compound hetero-
zygous for an in-frame 3 bp deletion in exon 14 (c.1899_1901del, p.E634del) and a nonsense
mutation c.1525C>T, p.R509� in exon 11. Mutation c.1899_1901del mutation was inherited
on the maternal allele and the c.1525C>T paternally. Healthy sister B.II.1 is heterozygous for
the maternal mutation, healthy sister B.II.3 is a heterozygous carrier of the paternal mutation
(Fig 1A, pedigree Family B).
Structure modelling
Human NUP88 protein sequence Q99567 (UniProt database) was used for structural investi-
gation and modelling using an N-terminal and C-terminal part, according to predictions.
Database search comparisons using HHPRed [41–45] revealed as best hits for the N-terminal
domain (NTD): Nuclear pore complex proteins Nup82 from S. cerevisiae and Chaetomium
thermophilum (PDBid: 3pbp A, 3tkn_A and 5cww_B, respectively) and for the C-terminal
domain (CTD) Nup57 from Chaetomium thermophilum (PDBid: 5cws E) and Nup54 from
Homo sapiens (PDBid: 5ijn F). The high similarity to yeast and Chaetomium Nup82, the struc-
tures of which have been solved in part [46–48] strongly indicate that the NTD also forms a ß-
propeller and predictions suggest that the CTD is in an all helical arrangement (PsiPred and
JPred4) [49, 50]. In order to gain insight into the putative fold and the location of the disease-
related residues identified in hsNUP88, four servers were used for structure prediction.
Phyre2, Robetta, I-Tasser, RaptorX [51–57] were supplied with either full length sequence or
only the NTD (residues 1–495) or CTD (residues 496–741) in case of residue limitations or
implausible models resulting from full length submission. All modelling was performed using
standard settings. All figures were generated using Pymol.
Zebrafish husbandry
Zebrafish (Danio rerio) were raised and bred at 28˚C on a 14 h/10 h light/dark cycle.
Embryos and larvae were raised in egg water (0.3 g/l Instant Ocean Salt, 75 mg/l CaSO4; 1
mg/l Methylene Blue). The line carrying nup88sa2206 allele was obtained from Zebrafish
Mutation Project, Knockouts for Disease Models (http://www.sanger.ac.uk/sanger/
Zebrafish_Zmpgene/ENSDARG00000003235#sa2206). Heterozygous fish for nup88 were
out crossed for four generations with wild-type fish before analysis. All animal experiments
were performed in accordance with the rules of the State of Belgium (protocol approval
number: CEBEA-IBMM-2017-22:65).
RNA expression constructs
Capped messenger RNA was synthesized using the mMESSAGE mMACHINE kit (Ambion).
The following expression plasmids were generated and used in this study: the full-length zebra-
fish nup88 ORF was cloned from 48 hpf cDNA and recombined into BamHI-XhoI digested
pCS2 using In-fusion cloning (TaKaRa). nup88 mutants corresponding to the sequences iden-
tified in human fetal akinesia cases were generated by site-directed mutagenesis using Quik-
Change Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). All primer sequences
are listed in S2 Table. mRNAs (300 pg) were injected at the one-cell stage.
Genotyping and RT-PCR
nup88sa2206 genotyping was performed by RFLP assay using MseI restriction of a 150 bp PCR
product. Real-time PCR was done at various stages of embryonic and larval development
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(4-cell to 5 dpf). Primer sequences are listed in S2 Table. Staging of embryos was performed
according to [58].
Alcian blue staining
Alcian Blue staining and histology were performed as described elsewhere [59].
All images were acquired using an Olympus SZX16 stereomicroscope and an Olympus
XC50 camera using the imaging software Cell� after embryo anesthesia with a low dose of
tricaine.
Apoptosis assay using acridine orange in live embryos
Live embryos at 24 hpf, 36 hpf, 48 hpf were dechorionated and immersed in egg water contain-
ing 5 μg/ml acridine orange. They were incubated at 28.5˚C for 15 min in the dark and then
thoroughly washed with egg water. Embryos were mounted in low-melting agarose for posi-
tioning and immediately imaged using an Axio Observer Z1-1 microscope. Images were pro-
cessed using Zeiss Zen software.
Behavioral assays in zebrafish embryos and larvae
Spontaneous tail coiling of 22–24 hpf embryos, placed in the grooves of an agarose chamber,
was recorded for 2 min at 30 frames per second. Coiling events were scored manually. To ana-
lyze spontaneous locomotion, 4 dpf larvae were placed into 96-well plates (one larva per well).
Their behavior was recorded at 30 frames per second for 5 min and quantified using EthoVi-
sion XT 8.5 software (Noldus).
Touch-induced escape responses were analyzed in 4 dpf head-restrained larvae. Larvae
were first embedded in 2% low melting point agarose, and then the agarose surrounding their
tail was removed with a blade. Escape behavior was induced by touching the tail of larvae with
a plastic pipette tip and recorded at 300 frames per second. Duration of behavioral responses
was quantified with ImageJ.
qRT-PCR on 5 dpf zebrafish larvae
Total RNA of 5 dpf nup88 mutant and WT zebrafish larvae was extracted using TRIzol reagent
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol. Genomic DNA
was eliminated prior to reverse transcription using PrimeScript RT Reagent Kit with gDNA
Eraser (Perfect Real Time; RR047A, TaKaRa, Dalian, China). Total RNA (5 μg) was next
reverse-transcribed in 20 μl final volume according to manufacturer’s protocol. Primers for
target genes (S2 Table) were designed with Realtime PCR Tool by Integrated DNA Technolo-
gies, Inc (https://eu.idtdna.com/scitools/Applications/RealTimePCR), and sequences were
submitted to BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Quantitative PCR was then performed using SYBR Premix Ex Taq TM II (Tli RNaseH
Plus), Bulk kit (RR820L; Takara, Dalian, China). 1 μl of cDNA was used in each 20 μl-PCR
well with 300 nM primers pair final concentration. Each sample was assayed in triplicate and
samples not reverse-transcribed were used as negative controls. Eight housekeeping genes
were tested according to [60] and the most stable combination was determined using qbase
+ qPCR analysis software (https://www.qbaseplus.com). actb2, gapdh and ybx1 were the best
combination of housekeeping genes at this stage of larval development and used for
normalization.
Differences in amplification curves between the target genes and housekeeping genes were
identified by comparing standard curve slopes. Real-Time PCR was performed using Applied
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Biosystems StepOnePlus Real-Time PCR System and PCR analyses were performed with
qbase+ system software.
Zebrafish immunostaining
For whole-mount immunostaining, zebrafish embryos were fixed in 4% PFA for 3 h at room
temperature (RT), washed and permeabilized with proteinase K (40μg/ml) at 37˚C for 1 h. For
blocking, larvae were gently shaken in PBS containing 10% of normal goat serum, 1% DMSO
and 0.8% Triton X-100 for 1 h and then, incubated with the primary anti-acetylcholine recep-
tor antibody (mouse mAb35 (DSHB, Hybridoma Bank; 1:100) overnight at 4˚C. After wash-
ing, larvae were incubated with the secondary antibody (anti-mouse IgG Alexa Fluor 594,
1:1000) for 2 h at RT and washed six times for 15 min in PBST prior to mounting and confocal
imaging (Zeiss LSM710). Size of AChR cluster were determined using ImageJ.
Transmission electron microscopy of zebrafish skeletal muscle
Skeletal muscle of 5 dpf nup88+/+ and nup88-/- zebrafish larvae were analyzed by transmission
electron microscopy on longitudinal and transversal ultrathin sections.
Briefly, larvae were fixed in 2.5% glutaraldehyde and 0.1 M sodium cacodylate buffer, pH
7.4 overnight at 4˚C and post-fixed in 1% osmium tetroxide, 1.5% ferrocyanide in 0.15 M
cacodylate buffer for 1 h at RT. After serial dehydration in increasing ethanol concentrations,
samples were embedded in agar 100 (Agar Scientific Ltd., UK) and left to polymerize for 2
days at 60˚C. Ultrathin sections (80 nm thick) were collected using a Leica EM UC6 ultrami-
crotome and stained with uranyl acetate and lead citrate. Images were recorded on a Tecnai10
electron microscope (FEI) equipped with an Olympus VELETA camera and processed using
the AnalySIS software.
Immunohistochemistry-paraffin (IHC-P) labelling of fetal muscle sections
Brain and skeletal muscle paraffin-embedded blocks were obtained from autopsy of individual B.
II.2. Control tissues of a fetus of the same age without neuromuscular disorder were used for
IHC-P. Written consent form for use of paraffin samples for functional analysis was signed by the
parents. This study was performed according to the guidelines of the local ethics committee
(Ghent University Hospital), which does not require formal review for the use of autopsy samples.
Blocks were cut with a microtome and 5 μm sections were mounted. Sections were deparaffi-
nized and rehydrated. Heat-induced epitope retrieval was performed using Tris/EDTA, pH 9.0
for all tissues when using antibodies against rapsyn and with sodium citrate, pH 6.0 for anti-
nucleoporin antibody mAb414. 0.3% H2O2 for 20 min was used to block samples endogenous
peroxidase followed by washes with PBS. Tissues were permeabilized using PBS containing 0.5%
Triton X-100 for 5 min at RT and subsequently blocked with PBS containing 1% BSA for 30 min.
Primary antibodies were diluted in blocking buffer and incubated overnight at 4˚C in a humidifi-
cation chamber. Samples were washed in PBS for 10 min. Biotinylated goat anti-rabbit-Ig (1:400;
DAKO-E0432) or biotinylated goat anti-mouse (1:400; DAKO-E0433) were added for 30 min.
After washing in PBS, samples were incubated 30 min with streptavidin-HRP
(DAKO-P0397) diluted 1:300 in PBS and thoroughly washed with PBS. DAKO Liquid DAB
+ Substrate Chromogen System K3468 (1ml substrate + 1 drop DAB) was added on samples
and left until a brown coloring appeared (maximum 6 min). After several PBS washes, the
samples were counterstained with hematoxylin for 15 seconds, washed thoroughly under run-
ning tap water to remove excess staining agent and mounted for subsequent observations with
Aquatex. Images were acquired with an Olympus BX41 microscope and were processed using
the Olympus cellSense software.
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Plasmids for studies in human cell lines
For all constructs, human NUP88 was amplified by PCR. All constructs were verified by DNA
sequencing. GFP-NUP88 was produced as described previously [2]. FLAG-NUP88 was cloned
into KpnI/XbaI cut pFLAG-CMV2 (Sigma-Aldrich). GFP-NUP88 and FLAG-NUP88 mutants
were generated by site-directed mutagenesis using the QuikChange Lightning site-directed
mutagenesis kit (Agilent Technologies) following the manufacturer’s instructions. Primers are
listed in S2 Table.
Antibodies
The following polyclonal antibodies were used in this study for Western blotting (WB), immu-
nofluorescence (IF) and immunohistochemistry (IHC): rabbit anti-NUP214 (Abcam,
ab70497; WB 1:5000, IF 1:500), rabbit anti-lamin A (Sigma-Aldrich, L1293; WB 1:500), rabbit
anti-rapsyn (Novus Biologicals, NBP1-85537; WB 1:500; IHC 1:200), rabbit anti-MuSK (Ther-
moScientific, PA5-14705; WB 1:1000), rabbit anti-GAPDH (Cell Signaling, 2118; WB
1:10.000), rabbit anti-actin (Sigma-Aldrich, A2066; WB 1:1000), rabbit anti-Nesprin1 (Sigma-
Aldrich HPA019113; IF 1:250), rabbit anti-Nesprin2 (a kind gift of Dr. Iakowos Karakesiso-
glou; IF 1:50), rabbit anti-Sun1 (kind gift of Dr. Ulrike Kutay; IF 1:1000), rabbit anti-Sun2
(Sigma-Aldrich, HPA001209; IF 1:200), rabbit anti-emerin (Abcam, ab153718; IF 1:500), rab-
bit anti-NUP98 (Abcam, ab45584; WB 1:2000).
The following monoclonal antibodies were used in this study: mouse anti-Nup88 (BD
Transduction Laboratories, 611896; IF 1:500), mouse mAb414 (Covance MMS-120R; IF
1:2000; IHC 1:100), mouse anti-NUP62 (Clone 53, BD Transduction Laboratories, 610497;
WB 1: 3000, IF 1:500), mouse anti-lamin A/C (Abcam, ab8984; WB 1:300, IF 1:30), mouse
anti-FLAG (Sigma-Aldrich F-3165; IF: 1:200), rat anti-NUP98 (Sigma-Aldrich, N1038; WB IF
1:1000), mouse anti-AChR (mAb35, DSHB, Hybridoma Bank; IF 1:100), rat anti-GFP (3H9,
Chromotek; WB 1:1000).
Secondary antibodies for immunofluorescence were the corresponding goat anti-mouse-
IgG Alexa 568 (1:1000; Invitrogen), goat anti-rabbit IgG Alexa 568 (1:1000; Invitrogen). Sec-
ondary antibodies were either alkaline phosphatase coupled antibodies from Sigma/Aldrich
and used at 1:20.000 or HRP coupled antibodies from Cell Signaling Technology at 1:8000.
Cell culture and transfections
All experiments were conducted in HeLa cells (provided by Robert D. Goldman, Feinberg
School of Medicine, Northwestern University, Chicago, USA) grown in Dulbecco’s modified
Eagle’s medium (DMEM), supplemented with 10% fetal bovine serum (FBS) plus penicillin
and streptomycin. Cells were transfected with plasmids using Turbofect transfection reagent
(Thermo Scientific Fermentas, St. Leon-Rot, Germany), Lipofectamine 2000 (Life Technolo-
gies Invitrogen, Gent, Belgium) or jetPRIME (Polyplus, Illkirch, France) and with siRNAs
using Lipofectamine RNAiMAX (Life Technologies Invitrogen) following the instructions of
the manufacturer. Smart-pool small interfering RNAs were obtained from Dharmacon (GE
Healthcare Europe, Diegem, Belgium): human NUP88 (L-017547-01-0005), mouse NUP88
(L-054949-01-0005), and non-targeting siRNAs (D-001810-10).
Immunofluorescence microscopy of HeLa cells
HeLa cells were grown on glass coverslips, transfected, fixed in 4% PFA in PBS for 5 min, per-
meabilized with 0.5% Triton-X-100 in PBS for 5 min and then fixed again. Blocking was per-
formed with 2% BSA/0.1% Triton-X-100 in PBS for 30 min at RT. Primary antibodies were
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incubated at 4˚C over-night in a humidified chamber. Secondary antibodies were incubated 1
h at RT in the dark. Excess antibodies after primary and secondary antibody staining were
removed by three washing steps using 0.1% Triton-X-100 in PBS for 5 min. Cells were imaged
using a Zeiss LSM 710 (Zeiss, Oberkochen, Germany) confocal laser scanning microscope
with Zeiss Plan-Apochromat 63x/1.4 oil objective. Images were acquired using the microscope
system software and processed using Image J and Adobe Photoshop (Adobe Systems, Moun-
tain View, CA).
GFP-trap assay
HeLa cells, grown in a 10 cm dish, were transfected with GFP and GFP-NUP88 wild-type and
mutant variants, respectively. Cells were grown for 48 h at 37˚C in a humidified atmosphere
with 5% CO2. To harvest cells, growth medium was aspirated off, 1 ml of ice-cold PBS was
added to cells and cells were scraped from dish. The cells were transferred to a pre-cooled
tube, centrifuged at 500 xg for 3 min at 4˚C and the supernatant was discarded. The cell pellet
was washed twice with ice-cold PBS. Pellets were subsequently lysed with 200 μl of ice-cold
lysis buffer (10 mM Tris/HCl, pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP-40, protease-
phosphatase inhibitor) using a syringe before incubating on ice for 30 min. The tubes were
centrifuged for 15 min at 16.000 xg at 4˚C and the supernatant was transferred into a new reac-
tion tube.
Bradford assay was used to determine the protein concentration of the lysates and 300 μg of
protein lysate adjusted to 500 μl in dilution buffer (10 mM Tris/HCl, pH 7.5, 150 mM NaCl,
0.5 mM EDTA, protease-phosphatase inhibitor) was added to 25 μl of GFP-Trap_MA beads
(ChromoTek, Planegg-Martinsried, Germany). Beads were prewashed twice with dilution
buffer. The beads and the lysates were incubated 1h at 4˚C on an end-to-end rotor. The mag-
netic beads were then washed three times in dilution buffer containing 150 mM, 250 mM and
500 mM NaCl following the addition of 20 μl of 2x SDS-sample buffer (120 mM Tris/HCl, pH
6.8, 20% glycerol, 4% SDS, 0.04% bromophenol blue, 10% β-mercaptoethanol) and boiling at
95˚C for 10 min. The eluates were subsequently loaded on to 7% polyacrylamide gels and
Western blot was carried out (see below).
Western blotting
HeLa and C2C12 (provided by Vincent Mouly, The Pitie´-Salpêtrière Hospital, Institute of
Myology, Paris, France) cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.8, 150 mM
NaCl, 1% Nonidet-P40 and protease inhibitor cocktail tablets (Roche, Basel Switzerland)). 20 μg
of protein were loaded and separated by sodium dodecyl sulfate-polyacrylamide (5% or 7%) gel
electrophoresis (SDS-PAGE). The proteins were transferred onto a PVDF membrane (Immobi-
lon-P, Millipore) and the membranes were blocked with TBS containing 0.1% Tween 20 and
5% non-fat dry milk for 1 h. The membranes were then incubated for 1 h in blocking solution
containing a primary antibody followed by washing 3x in TBS containing 0.1% Tween 20 and
5% non-fat dry. The membranes were next incubated with secondary antibodies for 1 h, washed
3x in TBS and developed. X-ray films were scanned and processed using ImageJ.
Supporting information
S1 Methods. Supplementary methods.
(DOCX)
S1 Fig. (A) Sanger sequencing chromatograms of control (left) and fetal (fetus 5, Family 1)
DNA samples identifying the NM_002532.5 variant c.1300G>T. Exome sequencing (B) of
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fetus 2, Family 2.
(TIFF)
S2 Fig. (A) Expression of nup88 in developing zebrafish. Transcripts of nup88 were analyzed
by whole-mount in situ hybridization at the indicated developmental stages. nup88 transcripts
are maternally deposited during zebrafish oogenesis (4-cell stage). nup88 is further expressed
upon zygotic genome activation subsequently to mid-blastula transition (5 hpf and later).
nup88 is ubiquitously expressed up to 16 hpf and from 24 hpf prominent in the eye, brain and
anterior trunk. nup88 transcripts in somites are low (30 hpf—72 hpf). (B) The presence of
maternally deposited nup88 and zygotic nup88 transcripts was confirmed by RT-PCR at stages
4-cell to 5 dpf. actb2, gapdh and ybx1 were used as controls. (C) Acridine orange staining of
the tail region of wild-type and nup88-/- mutants at 36 hpf. No major apoptotic events were
detected. Shown are confocal images. Scale bars, 100 μm.
(TIFF)
S3 Fig. (A) Spontaneous movement (coiling behavior) of 22–24 hpf nup88+/+, nup88+/- and
nup88-/- embryos is identical. (B) Touch response is not impaired in nup88 mutant larvae at 3
dpf stage of development. Quantification of percentages of larvae displaying touch-induced
escape response (left) and response duration (right) in nup88+/+, nup88+/- and nup88-/-
embryos. n.s., not significant, two-tailed t-test (A, B right) or two-tailed Fisher exact test (B
left). Data are shown as mean ± SEM. n is number of embryos/larvae analyzed. (C) Quantifica-
tion of body length after microinjection of wild-type or the respective mutant nup88 were at
the one-cell stage. Body length was evaluated at 5 dpf and revealed non-statistically significant
differences were detected. Data are shown as mean ± SEM. n is number of embryos/larvae ana-
lyzed.
(TIFF)
S4 Fig. NUP88 binding properties and nuclear envelope organization of NUP88 mutants.
(A) All NUP88 mutants co-localize with the NPC-specific mAB414 antibodies in HeLa cells.
Wild-type NUP88, NUP88 D434Y, and NUP88 E634del localize to the NE and the cytoplasm,
whereas NUP88 R509� can additionally be found in the nucleus. (B) Nuclear envelope proteins
remain unaffected in the presence of mutant NUP88 based on lamin A/C distribution in HeLa
cells overexpressing GFP-NUP88 and GFP-NUP88 disease-related mutants. Cells in (A) and
(B) were analyzed by indirect immunofluorescence microscopy. Shown are confocal sections
on the midplane of the nuclear envelope. Scale bars, 10 μm. (C) Bacterially expressed glutathi-
one-S-transferase (GST), GST-NUP88 and GST-NUP88D434Y were bound to prewashed glu-
tathione sepharose beads and incubated with a total HeLa protein extract. Proteins were eluted
using Laemmli buffer and bound and unbound fractions were analyzed by immunoblotting
using anti-lamin A, anti-Nup214, and anti-actin antibodies. (D) HeLa cells transiently express-
ing green-fluorescent protein (GFP), GFP-NUP88 and GFP-NUP88 D434Y were lysed and
subjected to Western blot analysis using anti-NUP88, anti-lamin A/C antibodies. Actin served
as a loading control. NPCs show normal distribution in (E) the wild-type (WT) and nup88-/-
zebrafish as well as in (F) histological muscle sections from individual B.II.2 and a control
fetus. Shown are confocal images of sagittal cryo-sections of the diencephalon of 5 dpf zebra-
fish larvae and bright-field images of paraffin-embedded skeletal muscle section, respectively.
NPCs were visualized using the NPC-specific antibody mAB414 (red in (E), brown in (F)).
Scale bars: 5 μm (E), 20 μm (F).
(TIFF)
S5 Fig. Depletion of NUP88 does not affect the integrity of the nuclear envelope. Nuclear
envelope proteins remain unaffected in cells depleted for NUP88. Lamin A/C, emerin, Nesprin
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1, Nesprin 2, Sun1 and Sun2 distribution are similar in HeLa cells treated with control siRNA
and siRNA against NUP88, respectively. Cells were analyzed by indirect immunofluorescence
microscopy. Shown are confocal sections on the midplane of the nuclear envelope. Scale bars,
5 μm.
(TIFF)
S6 Fig. Nucleocytoplasmic transport remains unaltered upon expression of the NUP88
variants. Cells were transfected with plasmids coding for wild-type or mutant FLAG-tagged
NUP88 and for the nucleocytoplasmic transport substrates NES-GFP-cNLS, NES-GFP-M9
and GFP-NES (A) or the CRM1-cargoes GFP-mTor, GFP-SQSTM and GFP-TFEB (B). After
24 h, cells were subjected to indirect immunofluorescence and analyzed by confocal micros-
copy.
(TIFF)
S1 Table. Prediction tools.
(DOCX)
S2 Table. Sequences of oligonucleotide primers used for PCR and Sanger DNA sequencing.
(DOCX)
S1 Movie. Spontaneous tail coiling of nup88+/+, nup88+/- and nup88-/- embryos at 22–24
hpf. Movies were recorded for 2 min at 30 frames per second.
(AVI)
S2 Movie. Touch-induced escape response of 4 dpf head-restrained nup88+/+ larvae.
(AVI)
S3 Movie. Touch-induced escape response of 4 dpf head-restrained nup88+/- larvae.
(AVI)
S4 Movie. Touch-induced escape response of 4 dpf head-restrained nup88-/- larvae. Movies
2–4 were recorded at 300 frames per second.
(AVI)
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